Brexit talks on a knife edge, but investors may not feel impact for years

Published 09-DEC-2020 11:22 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Brexit talks may have entered the endgame, but for investors the final impact will not be known for years to come, warns Nigel Green the CEO of one of the world’s largest independent financial advisory and fintech organisations.

The warning comes as the EU and UK negotiation teams both reported no progress on Monday.

This was despite intensive talks over the past 48 hours which ended with a 90-minute phone call between UK Prime Minister Boris Johnson and European Commission President Ursula von der Leyen.

In a joint statement, the two leaders said: “The conditions for finalising an agreement are not there,” with the same three areas of contention: fisheries, the so-called level playing field for trade, and the enforcement of any deal.

Mr Green observed: “Brexit talks are on a knife edge – again – with gloomy prospects for a deal being struck in the last-minute talks.

“There’s a growing sense that time will run out and the final curtain will be brought down on 48 years of the UK membership of the European Union without a deal in place that covers annual trade worth almost $1 trillion.

“The uncertainty is making investors nervous.”

He continues: “However, the truth is the full economic impact of Brexit will not be known for many years to come as both sides make major readjustments to fit a new era.

“Despite considered economic models, no-one really knows whether the UK will perform better or not outside the EU, or whether the departure of a key member state will encourage reform in Brussels that could have positive long-term economic consequences across the bloc.

“With no helpful crystal balls, investors should worry less about the twists and turns of the Brexit talks and focus more on ensuring proper portfolio diversification – this means across regions, sectors and, importantly, currencies.

“This will best position investors to mitigate the unknown risks and capitalise on opportunities as they arise.”

The deVere CEO concludes: “The current standoff between London and Brussels should, of course, be monitored by investors. But it is the forthcoming readjustment phase that they should now be looking towards.

“Whatever happens, we can expect ongoing volatility, but this could also prove to be beneficial to those who are paying attention.”



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X